BioCrine Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 7
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.33M
Latest Deal Amount
  • Investors
  • 1

BioCrine General Information


Developer of pharmaceutical innovations for the treatment of diabetes. The company's goal is to commercialize new concepts of treatment and enable continual delivery of novel drugs both for diabetes itself and for the complications that the disease induces.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Parent Company
Primary Office
  • Sveavägen 166
  • Box 3073
  • 169 03 Solna
  • Sweden
+46 072-042 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCrine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 26-Sep-2013 $3.33M Completed Startup
2. Merger/Acquisition 29-Apr-2002 Completed Startup
1. Early Stage VC Completed Startup
To view BioCrine’s complete valuation and funding history, request access »

BioCrine Executive Team (3)

Name Title Board Seat Contact Info
Per-Olof Berggren Ph.D Founder, Chief Executive Officer & Board Member
Catharina Rahm Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

BioCrine Board Members (5)

Name Representing Role Since
Claes-Henrik Julander Self Board Member 000 0000
Gunnar Olsson Ph.D Self Board Member 000 0000
Kenth Petersson Self Chairman 000 0000
Martin Nicklasson Ph.D Self Board Member 000 0000
Per-Olof Berggren Ph.D BioCrine Founder, Chief Executive Officer & Board Member 000 0000
To view BioCrine’s complete board members history, request access »

BioCrine Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioCrine Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HealthCap Venture Capital Minority 000 0000 000000 0
To view BioCrine’s complete investors history, request access »